One-Year Review in Cardiac Arrest: The 2022 Randomized Controlled Trials
- PMID: 36983236
- PMCID: PMC10054058
- DOI: 10.3390/jcm12062235
One-Year Review in Cardiac Arrest: The 2022 Randomized Controlled Trials
Abstract
Cardiac arrest, one of the leading causes of death, accounts for numerous clinical studies published each year. This review summarizes the findings of all the randomized controlled clinical trials (RCT) on cardiac arrest published in the year 2022. The RCTs are presented according to the following categories: out-of- and in-hospital cardiac arrest (OHCA, IHCA) and post-cardiac arrest care. Interestingly, more than 80% of the RCTs encompassed advanced life support and post-cardiac arrest care, while no studies focused on the treatment of IHCA, except for one that, however, explored the temperature control after resuscitation in this population. Surprisingly, 9 out of 11 RCTs led to neutral results demonstrating equivalency between the newly tested interventions compared to current practice. One trial was negative, showing that oxygen titration in the immediate pre-hospital post-resuscitation period decreased survival compared to a more liberal approach. One RCT was positive and introduced new defibrillation strategies for refractory cardiac arrest. Overall, data from the 2022 RCTs discussed here provide a solid basis to generate new hypotheses to be tested in future clinical studies.
Keywords: cardiac arrest; cardiopulmonary resuscitation; outcome; randomized controlled trial.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Gräsner J.T., Herlitz J., Tjelmeland I.B.M., Wnent J., Masterson S., Lilja G., Bein B., Böttiger B.W., Rosell-Ortiz F., Nolan J.P., et al. European Resuscitation Council Guidelines 2021: Epidemiology of cardiac arrest in Europe. Resuscitation. 2021;161:61–79. doi: 10.1016/j.resuscitation.2021.02.007. - DOI - PubMed
-
- Yannopoulos D., Bartos J., Raveendran G., Walser E., Connett J., Murray T.A., Collins G., Zhang L., Kalra R., Kosmopoulos M., et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): A phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396:1807–1816. doi: 10.1016/S0140-6736(20)32338-2. - DOI - PMC - PubMed
-
- Belohlavek J., Smalcova J., Rob D., Franek O., Smid O., Pokorna M., Horák J., Mrazek V., Kovarnik T., Zemanek D., et al. Prague OHCA Study Group. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2022;327:737–747. doi: 10.1001/jama.2022.1025. - DOI - PMC - PubMed
-
- Gräsner J.T., Wnent J., Herlitz J., Perkins G.D., Lefering R., Tjelmeland I., Koster R.W., Masterson S., Rossell-Ortiz F., Maurer H., et al. Survival after out-of-hospital cardiac arrest in Europe—Results of the EuReCa TWO study. Resuscitation. 2020;148:218–226. doi: 10.1016/j.resuscitation.2019.12.042. - DOI - PubMed
